Progress in kidney transplant has improved survival while creating challenges. The pool of eligible patients is increasing, but organ supply remains inadequate. Waiting-list issues, adequate pretransplant assessment, judicious use of potent immunotherapy, and management of infections must be considered.
No takes yet. Share an insight, caveat, or question.
Joshua J. Augustine (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: